Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Over the past years, an increasing amount of evidence has emerged in support of the kynurenine pathway’s (KP) pivotal role in the pathogenesis of several neurodegenerative, psychiatric, vascular and autoimmune diseases. Different neuroactive metabolites of the KP are known to exert opposite effects...
Main Authors: | Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, László Vécsei |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/6/1564 |
Similar Items
-
Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
by: Gabriela D. Colpo, et al.
Published: (2019-07-01) -
Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
by: Ping Chen, et al.
Published: (2023-12-01) -
The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2017-06-01) -
Corrigendum: The Effect of Systemic Nitroglycerin Administration on the Kynurenine Pathway in the Rat
by: Gábor Nagy-Grócz, et al.
Published: (2020-09-01) -
The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
by: Onella Athnaiel, et al.
Published: (2022-10-01)